Yoav Golan

Yoav Golan, MD, MS, Associate professor, Tufts Medical Center. Dr. Golan is an attending physician at the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center, and an Associate Professor of Medicine at Tufts University School of Medicine. Dr. Golan is a graduate of the Hadassah School of Medicine at the Hebrew University in Jerusalem, Israel. He completed a medicine residency and Infectious Diseases fellowship at the Tel Aviv Sourasky Medical Center, followed by a transplant ID fellowship and masters in statistics and modelling at Tufts University School of Medicine. His research focuses on hospital-acquired infections with emphasis on ICU infections, the impact of antibiotic resistance on outcomes, patient risk stratification, and development of early culture-independent treatment strategies. Dr. Golan has a particular interest in the pharmacoeconomics of invasive fungal infections. He has contributed to the medical literature on patient risk stratification, identification of factors associated with the emergence of antibiotic resistance and the use of early antibiotic interventions among ICU patients. He is an author of 3 book chapters and numerous manuscripts and presentations. He received several patient-care and research awards.

Dr Golan’s interest in vaccination is in designing processes to ensure adherence with vaccination practices, improving immunization rates and advising hospitals on putting together a successful vaccination program. Dr Golan serves as the medical director for Delhaize America vaccination program. This program provides immunizations through hundreds of pharmacies located in super markets throughout the East Coast. Dr. designed the program, procedures, standing orders, quality assurance and monitoring to adverse events.

Sujun Zhang
Vice Minister of Justice of China

Sujun Zhang, vice minister of Justice of China since 2005. He is currently a senior visiting scholar at Kennedy School of Harvard University. He was born in Henan, China, had double degree from graduate school, he has over 20 year experience in executive management and leadership. He served as director of state prison, chair of state department of Justice, Jiangsu Province, chairperson of politics department- minister of Justice, China.

Steven L. Flamm

Steven L. Flamm, MD: Dr.Flamm is a Professor of Medicine and Surgery with the Division of Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. He also serves as the Medical Director of Liver Transplantation.Dr. Flamm received his MD degree from the University of Pennsylvania School of Medicine. He completed both a clinical fellowship in gastroenterology and a research fellowship in gastroenterology and hepatology at Beth Israel Hospital, Harvard Medical School. He then went on for further specialized training, completing a clinical fellowship in hepatology and liver transplantation at The Deaconess Hospital, Harvard Medical School. He has served as the Region 7 Representative to the UNOS Liver and Intestine Committee and on the Publication and Practice Guidelines Committees of the AASLD. Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many other liver-related topics including viral hepatitis, autoimmune hepatitis, hepatic encephalopathy, and liver transplantation. He has an active clinical research program for patients with many different chronic liver diseases including chronic viral hepatitis (HBV and HCV).

Raymond Chung

Raymond Chung, M.D.: Dr. Chung is Associate Professor of Medicine at Harvard Medical School and Director of Hepatology and Vice Chief of Gastroenterology at Massachusetts General Hospital. He received his degree from Yale University School of Medicine in 1986 and obtained his Clinical & Research Fellowship training in the Massachusetts General Hospital. Dr. Chung’s major research focus is HCV infection. Specifically, he is interested in delineating the mechanisms of HCV persistence and identifying host factors that support viral replication. Dr. Chung’s lab is also interested in elucidating the molecular basis for the accelerated liver disease pathogenesis in HCV-HIV co-infection. His lab has been consistently funded and is the principal site for an NIH Cooperative Center for Human Immunology, a consortium of 8 projects devoted to understanding the mechanisms of immune failure operative in chronic hepatitis C virus disease.

Yuanli Liu

Yuanli Liu Ph.D.: Dr. Yuanli Liu is the founding Director of China Initiative at Harvard School of Public Health (HSPH). He has worked in many African and Asian developing countries. In particular, he has been closely involved in helping inform China’s health policy making process for series of reforms and strategic developments. Since 2006, he has been leading the Harvard China Initiative to conduct series of high impact programs in healthcare reform research, leadership development and policy dialogues. Dr. Liu also served on the United Nations Millennium Development Taskforce on HIV/AIDS, Malaria, TB, and Access to Basic Medicines. He consulted for many international agencies including the World Health Organization, World Bank, Asian Development Bank, UNICEF. He is also an Adjunct Professor of Tsinghua University and currently serves on the Experts Committee of Health Policy and Management of the Chinese Ministry of Health.

Edison Wong

Edison Wong, M.D., M.S.: Dr. Wong is a board certified specialist in physical medicine and rehabilitation. His major focus is on chronic pain management. For the past 7 years, he owned and ran a pain clinic in Central Massachusetts, where he is the only comprehensive non-interventional pain management provider. He manages pain with a combination of opiate and non-opiate medications, physical and occupational therapies, modalities, complimentary and alternative medicine techniques, chronic pain and other counseling, lifestyle modifications, and medical problem solving. He is Director of Medical Education at Health Alliance Hospital in Leominster, MA and sits on the CME committees of his local and state medical societies. He is currently affiliated with the Department of Family Medicine at UMass Medical School as a clinical instructor, and had been on the faculty of Harvard Medical School’s Department of Physical Medicine and Rehabilitation for 7 years. He has years of experience in Traumatic Brain Injury Rehabilitation including running two major inpatient head trauma units (Spaulding Rehab hospital & Shaughnessy-Kaplan Rehab Hospital). He has lectured on numerous rehab topics ranging from head trauma to stroke to amputation to pain management. He has spoken internationally at rehab hospitals in Poland and Scotland on topics about Head Trauma. He started one of the two major Vision Rehab clinics in the state and started the first Web sites for two major hospitals (Spaulding Rehab Hospital and the North Shore Medical Center). He also actively speaks for several pharma companies for both opiate and non-opiate pain medications.

William Shaw

William Shaw, PhD: Dr. Shaw is board certified in the fields of clinical chemistry and toxicology by the American Board of Clinical Chemistry. Before he founded The Great Plains Laboratory, Inc., Dr. Shaw worked for the Centers for Disease Control and Prevention (CDC), Children’s Mercy Hospital, University of Missouri at Kansas City School of Medicine, and Smith Kline Laboratories. He is the author of Biological Treatments for Autism and PDD, originally published in 1998 and Autism: Beyond the Basics, published in 2009. He is also a frequent speaker at conferences worldwide. He is the stepfather of a child with autism and has helped thousands of patients and medical practitioners to successfully improve the lives of people with autism, AD(H)D, Alzheimer’s disease, arthritis, bipolar disorder, chronic fatigue, depression, fibromyalgia, immune deficiencies, multiple sclerosis, OCD, Parkinson’s disease, seizure disorders, tic disorders, Tourette syndrome, and other serious conditions.

Presentation highlight: Throughout the last century, society has been exposed to unregulated and potentially dangerous chemicals. A thorough discussion of the most common toxins that have an effect on physical, behavioral and mental health will be presented including heavy metals, triclosan, PCBs, phthalates, organophosphates, and others. This research-based presentation will address the most common and problematic toxic chemicals, their sources, along with detection and treatment options.

Sally Brockett

Sally Brockett, MS. Sally Brockett is the Director of the IDEA Training and Consultation Center in North Haven, Connecticut. She founded the center in 1992 to focus on interventions for developmental disabilities after 12 years as a special education teacher with all categories of disabilities. After training in France with Dr. Guy Berard, the Berard method of auditory integration training (AIT) and consultation became a special focus of her work. Mrs. Brockett has completed advanced training in AIT with Dr. Guy Berard and currently works as the world-wide representative for his program. She is a certified International Professional Instructor in the Berard method. Mrs. Brockett founded the Berard AIT International Society and has served on the Board of Directors since its beginning. She and Dr. Berard have co-authored Hearing Equals Behavior: Updated and Expanded, the newest edition of Dr. Berard's book about his method of auditory integration training.

Presentation highlight: Can 10 hours of listening to electronically modulated music really create significant improvements in behavior and academic abilities for individuals on the autism spectrum? This presentation will provide a description of the procedure and a review of data collected before and after the intervention.